<DOC>
	<DOCNO>NCT00249041</DOCNO>
	<brief_summary>The purpose study ass antibody formation Enbrel liquid subject Rheumatoid Arthritis</brief_summary>
	<brief_title>Enbrel Liquid Immunogenicity Protocol</brief_title>
	<detailed_description>The purpose study assess rate anti-etanercept antibody formation large sample subject liquid etanercept previous study , 20020378 , minimum 400 subject receive etanercept liquid first time , without concomitant MTX therapy . The rate neutralizing antibody liquid etanercept also assess .</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Etanercept</mesh_term>
	<criteria>18 year age old Must able selfinject someone Should Rheumatoid Arthritis per ARA criterion screen lab result per predefined value Any prior biologic therapy inflammatory disease Any prior cyclophosphamide therapy Not use adequate contraception Pregnant breastfeeding significant concurrent medical condition</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2010</verification_date>
	<keyword>Rheumatoid Arthritis , Enbrel liquid , antibody</keyword>
</DOC>